Sherry Ci
Impact in
- Biomaterials top 5%
- Nanoparticle-Based Drug Delivery
- Oncology top 10%
- Cancer Treatment and Pharmacology
- HER2/EGFR in Cancer Research
- Pancreatic and Hepatic Oncology Research
Papers in
- Oncology 5
- Cancer Treatment and Pharmacology 5
- Metal complexes synthesis and properties 1
-
- Protein purification and stability 1
Sherry Ci
7 papers receiving 947 citations
Sherry Ci's Hit Papers
Peers
Comparison fields: 5 of 94
- Biomaterials 371
- Oncology 452
- Pharmaceutical Science 62
- Cancer Research 115
- Pulmonary and Respiratory Medicine 168
Countries citing papers authored by Sherry Ci
This map shows the geographic impact of Sherry Ci's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sherry Ci with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sherry Ci more than expected).
Fields of papers citing papers by Sherry Ci
This network shows the impact of papers produced by Sherry Ci. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sherry Ci. The network helps show where Sherry Ci may publish in the future.
Co-authors
The 11 scholars most cited alongside Sherry Ci, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Increased antitumor activity, intratumor paclitaxel concentrations, and endothelial cell transport of cremophor-free, albumin-bound paclitaxel, ABI-007, compared with cremophor-based paclitaxel. Hit paper breakdown → | 2006 | 901 |
| 2 | 1999 | 46 | |
| 3 | Enhanced efficacy and safety of nanoparticle albumin-bound nab-docetaxel versus taxotere. | 2006 | 9 |
| 4 | Characterization and in vitro/in vivo dissolution of nab-paclitaxel nanoparticles | 2008 | 7 |
| 5 | Comparison of physicochemical characteristics and stability of three novel formulations of paclitaxel: Abraxane, Nanoxel, and Genexol PM | 2008 | 5 |
| 6 | Nanoparticle albumin-bound (nab) rapamycin as an anticancer agent | 2007 | 5 |
| 7 | Pharmacokinetic and ADME study of nanoparticle albumin-bound 17AAG (nab-17AAG) in mice | 2008 | 2 |
About Sherry Ci
Sherry Ci is a scholar working on Oncology, Molecular Biology, Biomaterials, Cancer Research and Aquatic Science, having authored 7 papers that have together received 975 indexed citations. Recurring topics across this work include Cancer Treatment and Pharmacology (5 papers), Nanoparticle-Based Drug Delivery (2 papers), Plant-based Medicinal Research (1 paper), Computational Drug Discovery Methods (1 paper), Protein purification and stability (1 paper), Radiopharmaceutical Chemistry and Applications (1 paper), Metal complexes synthesis and properties (1 paper) and Analytical Chemistry and Chromatography (1 paper). The work is most often cited by research in Biomaterials (371 citations), Oncology (452 citations), Pharmaceutical Science (62 citations), Cancer Research (115 citations) and Pulmonary and Respiratory Medicine (168 citations). Frequent co-authors include Neil Desai, Andrew Yang, Patrick Soon‐Shiong, Leslie Louie, Vuong Trieu, Tapas De, Michael Hawkins, Patricia E. Noker, Zhiwen Yao and Donald J. Dykes. Their work appears in journals such as Cancer Research, Clinical Cancer Research and Journal of Chromatography A.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.